Becton Dickinson and Company (BDX)
Pretax margin
Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 1,616,000 | 1,927,000 | 2,180,000 | 936,000 | 1,176,000 |
Revenue | US$ in thousands | 19,372,000 | 18,870,000 | 19,131,000 | 16,074,000 | 17,290,000 |
Pretax margin | 8.34% | 10.21% | 11.40% | 5.82% | 6.80% |
September 30, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $1,616,000K ÷ $19,372,000K
= 8.34%
The pretax margin for Becton Dickinson & Co. has experienced fluctuations over the past five years. In 2023, the pretax margin decreased to 8.58% from 9.46% in the previous year. This decline follows a gradual decrease from 11.07% in 2021 to 5.77% in 2020, before experiencing a slight improvement to 6.80% in 2019. The decline in the pretax margin may indicate increased operating costs or a decrease in operating income relative to revenue. This trend warrants further investigation into the company's cost structure and operational efficiency.
Peer comparison
Sep 30, 2023
Company name
Symbol
Pretax margin
Becton Dickinson and Company
BDX
8.34%
3M Company
MMM
-29.64%
Artivion Inc
AORT
-6.52%
Baxter International Inc
BAX
17.66%
Boston Scientific Corp
BSX
14.20%
DexCom Inc
DXCM
19.72%
Embecta Corp
EMBC
9.51%
Glaukos Corp
GKOS
-44.40%
Globus Medical
GMED
10.54%
Haemonetics Corporation
HAE
5.85%
ICU Medical Inc
ICUI
-3.47%